• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Hidden Heart Disease: Shedding Light on Cardiac Amyloidosis.

作者信息

Tsai Cheng-Hsuan, Lin Yen-Hung, Wu Yen-Wen

机构信息

Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University.

Cardiovascular Center, National Taiwan University Hospital, Taipei.

出版信息

Acta Cardiol Sin. 2023 Jul;39(4):544-545. doi: 10.6515/ACS.202307_39(4).20230526A.

DOI:10.6515/ACS.202307_39(4).20230526A
PMID:37456941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10346058/
Abstract
摘要

相似文献

1
The Hidden Heart Disease: Shedding Light on Cardiac Amyloidosis.隐匿性心脏病：揭示心脏淀粉样变性
Acta Cardiol Sin. 2023 Jul;39(4):544-545. doi: 10.6515/ACS.202307_39(4).20230526A.
2
Cardiac Transthyretin Amyloidosis: Hidden in Plain Sight.心脏转甲状腺素蛋白淀粉样变性：隐匿于众目睽睽之下。
Case Rep Med. 2021 Dec 7;2021:2551964. doi: 10.1155/2021/2551964. eCollection 2021.
3
Prognostic value of depressed midwall systolic function in cardiac light-chain amyloidosis.心肌轻链淀粉样变性中室壁中层收缩功能减低的预后价值
J Hypertens. 2014 May;32(5):1121-31; discussion 1131. doi: 10.1097/HJH.0000000000000120.
4
Accelerated junctional rhythm (AJR) revealing light-chain cardiac amyloidosis: A case report with literature review.加速性交界性心律揭示轻链型心脏淀粉样变性：一例报告并文献复习
Ann Med Surg (Lond). 2022 Mar 3;75:103410. doi: 10.1016/j.amsu.2022.103410. eCollection 2022 Mar.
5
Light-Chain (AL) Cardiac Amyloidosis Presenting as Heart Failure With Reduced Ejection Fraction.轻链型（AL）心脏淀粉样变性表现为射血分数降低的心力衰竭。
Cureus. 2024 Feb 29;16(2):e55271. doi: 10.7759/cureus.55271. eCollection 2024 Feb.
6
Outcomes in Patients With Cardiac Amyloidosis Undergoing Heart Transplantation.接受心脏移植的心脏淀粉样变性患者的结局。
JACC Heart Fail. 2020 Jun;8(6):461-468. doi: 10.1016/j.jchf.2019.12.013. Epub 2020 May 6.
7
Cardiac amyloidosis: updates in diagnosis and management.心脏淀粉样变性：诊断与治疗进展。
Arch Cardiovasc Dis. 2013 Oct;106(10):528-40. doi: 10.1016/j.acvd.2013.06.051. Epub 2013 Sep 23.
8
Harnessing Cardiac Regeneration as a Potential Therapeutic Strategy for AL Cardiac Amyloidosis.利用心脏再生作为治疗心脏淀粉样变的潜在治疗策略。
Curr Cardiol Rep. 2020 Jan 13;22(1):1. doi: 10.1007/s11886-020-1252-3.
9
Cardiac transplantation followed by dose-intensive melphalan and autologous stem-cell transplantation for light chain amyloidosis and heart failure.心脏移植后继以剂量密集美法仑和自体干细胞移植治疗轻链淀粉样变性和心力衰竭。
Transplantation. 2010 Oct 27;90(8):905-11. doi: 10.1097/TP.0b013e3181f10edb.
10
Light-chain cardiac amyloidosis.轻链型心脏淀粉样变性
Curr Probl Cancer. 2017 Mar-Apr;41(2):144-156. doi: 10.1016/j.currproblcancer.2016.11.004. Epub 2016 Nov 17.

引用本文的文献

1
Effect of Tafamidis on Clinical and Functional Parameters in Transthyretin Amyloid Cardiomyopathy.他法米地对转甲状腺素蛋白淀粉样心肌病临床及功能参数的影响
JACC Adv. 2025 Feb;4(2):101511. doi: 10.1016/j.jacadv.2024.101511. Epub 2024 Dec 19.
2
2025 Update Consensus of Tc-Pyrophosphate Scintigraphy in the Transthyretin Cardiac Amyloidosis from the Taiwan Society of Cardiology and the Society of Nuclear Medicine of the Republic of China.2025年台湾心脏病学会与中华民国核医学会关于转甲状腺素蛋白心脏淀粉样变的锝-焦磷酸盐闪烁扫描术的更新共识
Acta Cardiol Sin. 2025 Jan;41(1):55-71. doi: 10.6515/ACS.202501_41(1).20241027A.

本文引用的文献

1
Efficacy of Tafamidis in Patients with Ala97Ser Hereditary Transthyretin Cardiac Amyloidosis: A Six-Month Follow-Up Study.他法米地斯治疗Ala97Ser遗传性转甲状腺素蛋白心脏淀粉样变性患者的疗效：一项为期6个月的随访研究。
Acta Cardiol Sin. 2023 Jul;39(4):619-627. doi: 10.6515/ACS.202307_39(4).20221116A.
2
2023 Expert Consensus of the Taiwan Society of Cardiology on the Diagnosis and Treatment of Cardiac Amyloidosis.台湾心脏病学会2023年心脏淀粉样变诊断与治疗专家共识
Acta Cardiol Sin. 2023 Jul;39(4):511-543. doi: 10.6515/ACS.202307_39(4).20230610A.
3
Tafamidis Treatment Decreases Tc-Pyrophosphate Uptake in Patients With Hereditary Ala97Ser Transthyretin Amyloid Cardiomyopathy.他法米地治疗可降低遗传性Ala97Ser转甲状腺素蛋白淀粉样心肌病患者的锝-焦磷酸盐摄取。
JACC Cardiovasc Imaging. 2023 Jun;16(6):866-867. doi: 10.1016/j.jcmg.2022.12.016. Epub 2023 Feb 8.
4
Reverse cardiac remodelling and dysfunction in A97S transthyretin cardiac amyloidosis after tafamidis treatment.特立氟胺治疗后 A97S 转甲状腺素蛋白心脏淀粉样变的心脏逆重构和功能障碍。
ESC Heart Fail. 2022 Dec;9(6):4335-4339. doi: 10.1002/ehf2.14165. Epub 2022 Sep 20.
5
2021 Advocacy Statements for the Role of Tc-Pyrophosphate Scintigraphy in the Diagnosis of Transthyretin Cardiac Amyloidosis: A Report of the Taiwan Society of Cardiology and the Society of Nuclear Medicine of the Republic of China.2021年锝-焦磷酸盐闪烁扫描术在转甲状腺素蛋白心脏淀粉样变诊断中作用的宣传声明：中华民国台湾心脏病学会和核医学会报告
Acta Cardiol Sin. 2021 May;37(3):221-231. doi: 10.6515/ACS.202105_37(3).20210420A.
6
Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association.心脏淀粉样变性：不断发展的诊断和治疗——美国心脏协会的科学声明。
Circulation. 2020 Jul 7;142(1):e7-e22. doi: 10.1161/CIR.0000000000000792. Epub 2020 Jun 1.
7
Cardiac manifestations and prognostic implications of hereditary transthyretin amyloidosis associated with transthyretin Ala97Ser.与转甲状腺素蛋白 Ala97Ser 相关的遗传性转甲状腺素蛋白淀粉样变性的心脏表现和预后意义。
J Formos Med Assoc. 2020 Mar;119(3):693-700. doi: 10.1016/j.jfma.2019.08.027. Epub 2019 Sep 11.
8
Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review.转甲状腺素蛋白淀粉样心肌病：美国心脏病学会最新临床综述
J Am Coll Cardiol. 2019 Jun 11;73(22):2872-2891. doi: 10.1016/j.jacc.2019.04.003.
9
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.特发性甲状腺素运载蛋白淀粉样变心肌病患者的塔法米迪治疗。
N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27.
10
Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness.在左心室壁增厚的患者中遗传性转甲状腺素蛋白淀粉样心肌病的患病率和临床表型。
Eur Heart J. 2016 Jun 14;37(23):1826-34. doi: 10.1093/eurheartj/ehv583. Epub 2015 Nov 3.